{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:40:29Z","timestamp":1780087229706,"version":"3.54.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11481-021-10048-x","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T10:03:22Z","timestamp":1641463402000},"page":"526-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Higher Levels of IgG3 Antibodies in Serum, But Not in CSF, Distinguish Multiple Sclerosis From Other Neurological Disorders"],"prefix":"10.1007","volume":"17","author":[{"given":"Peter G. E.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Graner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Fringuello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Pointon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinda","family":"Alquatli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4850-8586","authenticated-orcid":false,"given":"Xiaoli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"10048_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24088","volume":"75","author":"J Bankoti","year":"2014","unstructured":"Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, Von B\u00fcdingen HC (2014) In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. Ann Neurol 75:266\u2013276","journal-title":"Ann Neurol"},{"key":"10048_CR2","doi-asserted-by":"crossref","unstructured":"Bakshi R, Yeste A, Patel B, Tauhid S, Tummala S, Rahbari R, Chu R, Regev K, Kivis\u00e4kk P, Weiner HL, Quintana FJ (2016) Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 3:e200","DOI":"10.1212\/NXI.0000000000000200"},{"key":"10048_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24088","volume":"75","author":"J Bankoti","year":"2014","unstructured":"Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, Von B\u00fcdingen HC (2014) In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. Ann Neurol 75:266\u2013276","journal-title":"Ann Neurol"},{"key":"10048_CR4","doi-asserted-by":"crossref","unstructured":"Beseler C, Vollmer T, Graner M, Yu X (2017) The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution PLoS One 12:\u00a0e0186842","DOI":"10.1371\/journal.pone.0186842"},{"key":"10048_CR5","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1073\/pnas.1522730113","volume":"113","author":"SM Brandle","year":"2016","unstructured":"Brandle SM, Obermeier B, Senel M, Bruder J, Mentele R, Khademi M, Olsson T, Tumani H, Kristoferitsch W, Lottspeich F, Wekerle H, Hohlfeld R, Dornmair K (2016) Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins. Proc Natl Acad Sci U S A 113:7864\u20137869","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10048_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ana.23749","volume":"73","author":"Buck, D., Albrecht, E., Aslam, M., Goris, A., Hauenstein, N., Jochim, A., International Multiple Sclerosis Genetics, C., Wellcome Trust Case Control, C., Cepok, S., Grummel, V., Dubois, B., Berthele, A., Lichtner, P., Gieger, C., Winkelmann, J., and Hemmer, B","year":"2013","unstructured":"Buck, D., Albrecht, E., Aslam, M., Goris, A., Hauenstein, N., Jochim, A., International Multiple Sclerosis Genetics, C., Wellcome Trust Case Control, C., Cepok, S., Grummel, V., Dubois, B., Berthele, A., Lichtner, P., Gieger, C., Winkelmann, J., and Hemmer, B (2013) Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 73:86\u201394","journal-title":"Ann Neurol"},{"key":"10048_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","volume":"40","author":"T Damelang","year":"2019","unstructured":"Damelang T, Rogerson SJ, Kent SJ, Chung AW (2019) Role of IgG3 in Infectious Diseases. Trends Immunol 40:197\u2013211","journal-title":"Trends Immunol"},{"key":"10048_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5455\/medarh.2013.67.368-371","volume":"67","author":"M Delic-Sarac","year":"2013","unstructured":"Delic-Sarac M, Izetbegovic S, Karamehic J, Subasic D, Saban A, Jukic T, Coric J, Panjeta M (2013) Detection methods of immunoglobulin IgG in CSF and serum. Med Arch 67:368\u2013371","journal-title":"Med Arch"},{"key":"10048_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00313357","volume":"211","author":"P Delmotte","year":"1976","unstructured":"Delmotte P, Demonty L (1976) Biochemical findings in multiple sclerosis. II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls. J Neurol 211:135\u2013142","journal-title":"J Neurol"},{"key":"10048_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jns.2009.09.016","volume":"288","author":"F Di Pauli","year":"2010","unstructured":"Di Pauli F, Gredler V, Kuenz B, Lutterotti A, Ehling R, Gneiss C, Schocke M, Deisenhammer F, Reindl M, Berger T (2010) Features of intrathecal immunoglobulins in patients with multiple sclerosis. J Neurol Sci 288:147\u2013150","journal-title":"J Neurol Sci"},{"key":"10048_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12974-017-0812-y","volume":"14","author":"G Farina","year":"2017","unstructured":"Farina G, Magliozzi R, Pitteri M, Reynolds R, Rossi S, Gajofatto A, Benedetti MD, Facchiano F, Monaco S, Calabrese M (2017) Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. J Neuroinflammation 14:40","journal-title":"J Neuroinflammation"},{"key":"10048_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jneuroim.2014.06.010","volume":"274","author":"D Ferreira","year":"2014","unstructured":"Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund LO, Hillert J, Westman E, Karrenbauer VD (2014) Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy. J Neuroimmunol 274:149\u2013154","journal-title":"J Neuroimmunol"},{"key":"10048_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archneur.1971.00490060060006","volume":"25","author":"M Fischer-Williams","year":"1971","unstructured":"Fischer-Williams M, Roberts RC (1971) Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class. Arch Neurol 25:526\u2013534","journal-title":"Arch Neurol"},{"key":"10048_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1172\/JCI112801","volume":"79","author":"CN Gaiser","year":"1987","unstructured":"Gaiser CN, Johnson MJ, De Lange G, Rassenti L, Cavalli-Sforza LL, Steinman L (1987) Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism. J Clin Invest 79:309\u2013313","journal-title":"J Clin Invest"},{"key":"10048_CR15","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/jnnp.49.9.1066","volume":"49","author":"A Garc\u00eda-Merino","year":"1986","unstructured":"Garc\u00eda-Merino A, Persson MA, Ernerudh J, D\u00edaz-Gil JJ, Olsson T (1986) Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis. J Neurol Neurosurg Psychiatry 49:1066\u20131070","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10048_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1474-4422(05)70023-5","volume":"4","author":"DH Gilden","year":"2005","unstructured":"Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4:195\u2013202","journal-title":"Lancet Neurol"},{"key":"10048_CR17","first-page":"102","volume":"48","author":"P Glynn","year":"1982","unstructured":"Glynn P, Gilbert HM, Newcombe J, Cuzner ML (1982) Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies. Clin Exp Immunol 48:102\u2013110","journal-title":"Clin Exp Immunol"},{"key":"10048_CR18","doi-asserted-by":"crossref","unstructured":"Graner M, Pointon T, Manton S, Green M, Dennison K, Davis M, Braiotta G, Craft J, Edwards T, Polonsky B, Fringuello A, Vollmer T, Yu X (2020). Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides. PLoS One 15:e0228883","DOI":"10.1371\/journal.pone.0228883"},{"key":"10048_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0165-5728(01)00436-2","volume":"121","author":"B Greve","year":"2001","unstructured":"Greve B, Magnusson CG, Melms A, Weissert R (2001) Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis. J Neuroimmunol 121:120\u2013125","journal-title":"J Neuroimmunol"},{"key":"10048_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF02342029","volume":"7","author":"LM Grimaldi","year":"1986","unstructured":"Grimaldi LM, Maimone D, Reggio A, Raffaele R (1986) IgG1,3 and 4 oligoclonal bands in multiple sclerosis and other neurological diseases. Ital J Neurol Sci 7:507\u2013513","journal-title":"Ital J Neurol Sci"},{"key":"10048_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/jnnp.2008.150896","volume":"80","author":"FG Joseph","year":"2009","unstructured":"Joseph FG, Hirst CL, Pickersgill TP, Ben-Shlomo Y, Robertson NP, Scolding NJ (2009) CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. J Neurol Neurosurg Psychiatry 80:292\u2013296","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10048_CR22","doi-asserted-by":"publisher","first-page":"14987","DOI":"10.1038\/s41598-021-94423-x","volume":"11","author":"VD Karrenbauer","year":"2021","unstructured":"Karrenbauer VD, Bedri SK, Hillert J, Manouchehrinia A (2021) Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study. Sci Rep 11:14987","journal-title":"Sci Rep"},{"key":"10048_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/iai.26.3.933-941.1979","volume":"26","author":"WP Kaschka","year":"1979","unstructured":"Kaschka WP, Theilkaes L, Eickhoff K, Skvaril F (1979) Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis. Infect Immun 26:933\u2013941","journal-title":"Infect Immun"},{"key":"10048_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0009-8981(82)90063-8","volume":"121","author":"G Keir","year":"1982","unstructured":"Keir G, Walker RW, Johnson MH, Thompson EJ (1982) Nitrocellulose immunofixation following agarose electrophoresis in the study of immunoglobulin G subgroups in unconcentrated cerebrospinal fluid. Clin Chim Acta 121:231\u2013236","journal-title":"Clin Chim Acta"},{"key":"10048_CR25","doi-asserted-by":"crossref","unstructured":"Kennedy PGE, Graner M, Pointon T, Li X, Tanimoto K, Dennison K, Im G, Fringuello A, Zhou W, Graner A, Sillau S, Vollmer T, Yu X (2021) Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis. J Neuroimmune Pharmacol","DOI":"10.1007\/s11481-021-09996-1"},{"key":"10048_CR26","doi-asserted-by":"crossref","unstructured":"Kwon YN, Kim B, Kim JS, Mo H, Choi K, Oh SI, Kim JE, Nam TS, Sohn EH, Heo SH, Kim SB, Park KC, Yoon SS, Oh J, Baek SH, Kim BJ, Park KS, Sung JJ, Jung JH, Kim SJ, Park SH, Waters P, Kim SM (2022)\u00a0Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability. Neurol Neuroimmunol Neuroinflamm 9","DOI":"10.1212\/NXI.0000000000001095"},{"key":"10048_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0165-5728(91)90172-4","volume":"35","author":"P Lambin","year":"1991","unstructured":"Lambin P, Gervais A, Levy M, Defendini E, Dubarry M, Lebon P, Rouger P, Schuller E (1991) Intrathecal synthesis of IgG subclasses in multiple sclerosis and in acquired immunodeficiency syndrome (AIDS). J Neuroimmunol 35:179\u2013189","journal-title":"J Neuroimmunol"},{"key":"10048_CR28","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1179\/1743132813Y.0000000229","volume":"35","author":"Y Long","year":"2013","unstructured":"Long Y, Gao C, Qiu W, Hu X, Peng F, Lu Z (2013) Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients. Neurol Res 35:922\u2013929","journal-title":"Neurol Res"},{"key":"10048_CR29","first-page":"297","volume":"26","author":"J Losy","year":"1992","unstructured":"Losy J, Micha\u0142owska-Wender G, Wender M (1992) IgG1-IgG4 subclasses in the cerebrospinal fluid and blood serum and their synthesis in the central nervous system in multiple sclerosis. Neurol Neurochir Pol 26:297\u2013303","journal-title":"Neurol Neurochir Pol"},{"key":"10048_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0006-8993(71)90052-7","volume":"28","author":"CE Lumsden","year":"1971","unstructured":"Lumsden CE (1971) The immunogenesis of the multiple sclerosis plaque. Brain Res 28:365\u2013390","journal-title":"Brain Res"},{"key":"10048_CR31","doi-asserted-by":"crossref","unstructured":"Marsh-Wakefield F, Ashhurst T, Trend S, Mcguire HM, Juillard P, Zinger A, Jones AP, Kermode AG, Hawke S, Grau GE, Hart PH, Byrne SN (2020) IgG3 (+) B cells are associated with the development of multiple sclerosis. Clin Transl Immunology 9:e01133.","DOI":"10.1002\/cti2.1133"},{"key":"10048_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1749-6632.1988.tb27070.x","volume":"540","author":"PD Mehta","year":"1988","unstructured":"Mehta PD (1988) Quantitation of IgG subclasses in cerebrospinal fluid of patients with multiple sclerosis. Ann N Y Acad Sci 540:261\u2013263","journal-title":"Ann N Y Acad Sci"},{"key":"10048_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0022-510X(00)00292-6","volume":"175","author":"G Raknes","year":"2000","unstructured":"Raknes G, Fernandes Filho JA, Pandey JP, Myhr KM, Ulvestad E, Nyland H, Vedeler CA (2000) IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. J Neurol Sci 175:111\u2013115","journal-title":"J Neurol Sci"},{"key":"10048_CR34","first-page":"634","volume":"54","author":"JP Salier","year":"1983","unstructured":"Salier JP, Glynn P, Goust JM, Cuzner ML (1983) Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain. Clin Exp Immunol 54:634\u2013640","journal-title":"Clin Exp Immunol"},{"key":"10048_CR35","doi-asserted-by":"crossref","unstructured":"Shimizu F, Tasaki A, Sano Y, Ju M, Nishihara H, Oishi M, Koga M. Kawai M, Kanda T (2014) Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier. PLoS One 9:e92872","DOI":"10.1371\/journal.pone.0092872"},{"key":"10048_CR36","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3389\/fimmu.2018.01590","volume":"9","author":"S Trend","year":"2018","unstructured":"Trend S, Jones AP, Cha L, Byrne SN, Geldenhuys S, Fabis-Pedrini MJ, Carroll WM, Cole JM, Booth DR, Lucas RM, Kermode AG, French MA, Hart PH (2018) Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome. Front Immunol 9:1590","journal-title":"Front Immunol"},{"key":"10048_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0022-510X(82)90222-2","volume":"54","author":"F Vartdal","year":"1982","unstructured":"Vartdal F, Vandvik B (1982) Multiple sclerosis. Electrofocused \u201cbands\u201d of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses. J Neurol Sci 54:99\u2013107","journal-title":"J Neurol Sci"},{"key":"10048_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520","journal-title":"Front Immunol"},{"key":"10048_CR39","doi-asserted-by":"crossref","unstructured":"Yu X, Graner M, Kennedy PGE, Liu Y (2020) The Role of Antibodies in the Pathogenesis of Multiple Sclerosis. Front Neurol 11:533388","DOI":"10.3389\/fneur.2020.533388"},{"key":"10048_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/qjmed\/89.3.187","volume":"89","author":"AZ Zeman","year":"1996","unstructured":"Zeman AZ, Keir G, Luxton R, Thompson EJ (1996) Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source. QJM 89:187\u2013193","journal-title":"QJM"},{"key":"10048_CR41","doi-asserted-by":"publisher","first-page":"175628641987834","DOI":"10.1177\/1756286419878340","volume":"12","author":"G Zoehner","year":"2019","unstructured":"Zoehner G, Miclea A, Salmen A, Kamber N, Diem L, Friedli C, Bagnoud M, Ahmadi F, Briner M, S\u00e9dille-Mostafaie N, Kilidireas C, Stefanis L, Chan A, Hoepner R, Evangelopoulos ME (2019) Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Ther Adv Neurol Disord 12:1756286419878340","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-021-10048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-021-10048-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-021-10048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T02:09:06Z","timestamp":1673143746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-021-10048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":41,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10048"],"URL":"https:\/\/doi.org\/10.1007\/s11481-021-10048-x","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Interests"}}]}}